“pHGNS: A New Frontier in Sleep Surgery”

Tuesday, November 10, 2026 at 11:30am-12:30pm ET

Overview:

This session will review the neurophysiologic mechanisms, pivotal clinical evidence, patient selection considerations, and programming innovations underpinning proximal hypoglossal nerve stimulation (pHGNS) as a novel therapeutic approach for obstructive sleep apnea.

Learning Objectives:

After attending this session, participants will be able to:

  • Describe the neurophysiologic mechanisms and upper airway muscle recruitment patterns underlying proximal hypoglossal nerve stimulation (pHGNS).
  • Review clinical evidence supporting pHGNS, including outcomes from the OSPREY randomized clinical trial and emerging data on PolySync programming.
  • Evaluate patient selection considerations for pHGNS
  • Discuss high-level workflows around device activation, programming and optimizing therapeutic response to pHGNS

Speakers:

Robyn van Poelgeest, MD, PhD
Senior Director, OSA Medical Affairs at LivaNova

Ofer Jacobowitz, MD, PhD, FAASM
Co-Director of Sleep at ENT and Allergy Associates
Clinical Professor of Otolaryngology, Donald & Barbara Zucker School of Medicine

The SRS and the SRSF do not endorse any products discussed in this session.

Complimentary, Advanced Registration is Required. A recording of the webinar will be available at a later date.